The scrip opened at Rs. 1474 and has touched a high and low of Rs. 1492.75 and Rs. 1465 respectively.
Ajanta Pharma has announced that it has received U.S. FDA approval for Voriconazole Tablets.
Ajanta Pharma has announced that it has received U.S. FDA approval for Voriconazole Tablets.
Ajanta Pharma Ltd is currently trading at Rs. 1475, up by Rs. 0.65 or 0.04% from its previous closing of Rs. 1474.35 on the BSE.
The scrip opened at Rs. 1474 and has touched a high and low of Rs. 1492.75 and Rs. 1465 respectively. So far 40545(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 12975.02 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720 on 12-Aug-2015 and a 52 week low of Rs. 1103 on 18-Jan-2016. Last one week high and low of the scrip stood at Rs. 1586.5 and Rs. 1446 respectively.
The promoters holding in the company stood at 73.78 % while Institutions and Non-Institutions held 11.67 % and 14.55 % respectively.
The stock is currently trading above its 50 DMA.
No comments:
Post a Comment